Trial Outcomes & Findings for Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza (NCT NCT00756574)

NCT ID: NCT00756574

Last Updated: 2018-10-29

Results Overview

Laboratory confirmed influenza

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

447 participants

Primary outcome timeframe

one year

Results posted on

2018-10-29

Participant Flow

Participant milestones

Participant milestones
Measure
1. Surgical
surgical mask
2. N95 Respirator
N95 respirator
Overall Study
STARTED
225
221
Overall Study
COMPLETED
212
210
Overall Study
NOT COMPLETED
13
11

Reasons for withdrawal

Reasons for withdrawal
Measure
1. Surgical
surgical mask
2. N95 Respirator
N95 respirator
Overall Study
Withdrawal by Subject
9
7
Overall Study
Lost to Follow-up
4
4

Baseline Characteristics

Randomized Control Trial to Study the Efficacy of the Surgical Mask Versus the N95 Respirator to Prevent Influenza

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
1. Surgical
n=225 Participants
surgical mask
2. N95 Respirator
n=221 Participants
N95 respirator
Total
n=446 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
225 Participants
n=5 Participants
221 Participants
n=7 Participants
446 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
36.5 years
STANDARD_DEVIATION 10.6 • n=5 Participants
35.8 years
STANDARD_DEVIATION 10.6 • n=7 Participants
36.2 years
STANDARD_DEVIATION 10.6 • n=5 Participants
Sex: Female, Male
Female
212 Participants
n=5 Participants
208 Participants
n=7 Participants
420 Participants
n=5 Participants
Sex: Female, Male
Male
13 Participants
n=5 Participants
13 Participants
n=7 Participants
26 Participants
n=5 Participants
Region of Enrollment
Canada
225 participants
n=5 Participants
221 participants
n=7 Participants
446 participants
n=5 Participants

PRIMARY outcome

Timeframe: one year

Laboratory confirmed influenza

Outcome measures

Outcome measures
Measure
1. Surgical
n=212 Participants
surgical mask
2. N95 Respirator
n=210 Participants
N95 respirator
Laboratory-confirmed Influenza Infection
50 participants
48 participants

SECONDARY outcome

Timeframe: one year

visit to primary care MD

Outcome measures

Outcome measures
Measure
1. Surgical
n=212 Participants
surgical mask
2. N95 Respirator
n=210 Participants
N95 respirator
Physician Visits for Respiratory Illness
13 participants
13 participants

SECONDARY outcome

Timeframe: Over entire study period

Cough and fever

Outcome measures

Outcome measures
Measure
1. Surgical
n=212 Participants
surgical mask
2. N95 Respirator
n=210 Participants
N95 respirator
Influenza-like Illness
9 participants
2 participants

SECONDARY outcome

Timeframe: over study period

Absent from work because of flu-like illness

Outcome measures

Outcome measures
Measure
1. Surgical
n=212 Participants
surgical mask
2. N95 Respirator
n=210 Participants
N95 respirator
Absenteeism
42 participants
39 participants

Adverse Events

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Mark Loeb

McMaster University

Phone: 905-525-9140

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place